Literature DB >> 11384553

Mycobacterial Infections of the Head and Neck.

David C. Perlman1, Ron D'Amico, Nadim Salomon.   

Abstract

Mycobacteria are important causes of head and neck infections. Mycobacterial lymphadenitis may be caused by both Mycobacterium tuberculosis and a variety of nontuberculous myocbacteria. Changes in the epidemiology of tuberculosis have caused a shift of the peak age range of tuberculous lymphadenitis from childhood to ages 20 to 40 years. Short-course chemotherapy is highly effective. Mycobacterium avium has become the most common cause of nontuberculous lymphadenitis, but new mycobacterial species are increasingly recognized. Treatment consists primarily of complete surgical excision, although roles for antimycobacterial chemotherapy are being identified. Transient flares of mycobacterial lymphadenitis, which occur during initiation of antituberculous therapy and in HIV-infected patients after initiation of antiretroviral therapy, may respond to short courses of corticosteroids. Tuberculous otitis media has become uncommon. Otitis media due to nontuberculous mycobacterial infection is increasingly seen in patients with pre-existing ear disease and after surgical and otic interventions. Tuberculosis of the eye has also become uncommon but may occur via hematogenous dissemination or direct innoculation. Nontuberculous mycobacteria, most commonly Mycobacterium chelonae and Mycobacterium fortuitum, may cause keratitis, usually after some form of corneal trauma.

Entities:  

Year:  2001        PMID: 11384553     DOI: 10.1007/s11908-001-0025-4

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  55 in total

1.  Treatment of Bacillus Calmette-Guérin-associated lymphadenitis.

Authors:  F Oğuz; S Müjgan; G Alper; F Alev; O Neyzi
Journal:  Pediatr Infect Dis J       Date:  1992-10       Impact factor: 2.129

2.  Role of surgery in tuberculous mastoiditis.

Authors:  B Singh
Journal:  J Laryngol Otol       Date:  1991-11       Impact factor: 1.469

3.  Tuberculosis-related retinal vasculitis in an immunocompetent patient.

Authors:  J L Reny; G Challe; P Geisert; J Aerts; J M Ziza; G Raguin
Journal:  Clin Infect Dis       Date:  1996-05       Impact factor: 9.079

4.  Nontuberculous mycobacterial infection of the head and neck in immunocompetent children: CT and MR findings.

Authors:  C D Robson; R Hazra; P D Barnes; R L Robertson; D Jones; R N Husson
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

5.  Postoperative Mycobacterium chelonae endophthalmitis after extracapsular cataract extraction and posterior chamber intraocular lens implantation.

Authors:  A A Ramaswamy; J Biswas; V Bhaskar; L Gopal; R Rajagopal; H N Madhavan
Journal:  Ophthalmology       Date:  2000-07       Impact factor: 12.079

6.  A new agent of mycobacterial lymphadenitis in children: Mycobacterium heidelbergense sp. nov.

Authors:  W H Haas; W R Butler; P Kirschner; B B Plikaytis; M B Coyle; B Amthor; A G Steigerwalt; D J Brenner; M Salfinger; J T Crawford; E C Böttger; H J Bremer
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

7.  Obstetrical outcomes among women with extrapulmonary tuberculosis.

Authors:  N Jana; K Vasishta; S C Saha; K Ghosh
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

8.  Orbital-tuberculosis.

Authors:  P D'Souza; R Garg; R S Dhaliwal; R Jain; M Jain
Journal:  Int Ophthalmol       Date:  1994       Impact factor: 2.031

Review 9.  Chronic otitis media after tympanostomy tube placement caused by Mycobacterium abscessus: a new clinical entity?

Authors:  D J Franklin; J R Starke; M T Brady; B A Brown; R J Wallace
Journal:  Am J Otol       Date:  1994-05

Review 10.  Tuberculous otitis media.

Authors:  C M Kirsch; J H Wehner; W A Jensen; F T Kagawa; A C Campagna
Journal:  South Med J       Date:  1995-03       Impact factor: 0.954

View more
  9 in total

1.  Manifestations of HIV in the Head and Neck.

Authors:  Peter Sorensen
Journal:  Curr Infect Dis Rep       Date:  2011-04       Impact factor: 3.725

2.  Microbiology and Management of Sialadenitis.

Authors:  Patrick J. Bradley
Journal:  Curr Infect Dis Rep       Date:  2002-06       Impact factor: 3.725

3.  Manifestations of Tuberculosis in Otorhinolaryngology Practice: A Retrospective Study Conducted in a Coastal City of South India.

Authors:  Rithika Sriram; Kiran M Bhojwani
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-02-03

4.  Disseminated tuberculous lymphadenitis presenting as cervical mass in patient with HIV infection, worsening after antiretroviral initiation: diagnosis and treatment challenges.

Authors:  Alain Bruno Tagne Nouemssi
Journal:  BMJ Case Rep       Date:  2018-03-15

5.  Tuberculous disseminated lymphadenopathy in an immunocompetent non-HIV patient: a case report.

Authors:  Irini Gerogianni; Maria Papala; Konstantinos Kostikas; Maria Ioannou; Argiroula-Vasiliki Karadonta; Konstantinos Gourgoulianis
Journal:  J Med Case Rep       Date:  2009-12-03

6.  4 years' experience of head and neck tuberculosis in a south London hospital.

Authors:  N Choudhury; G Bruch; P Kothari; G Rao; R Simo
Journal:  J R Soc Med       Date:  2005-06       Impact factor: 18.000

7.  Potential role of (18)F-2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography imaging in patients presenting with generalized lymphadenopathy.

Authors:  Sellam Karunanithi; Ganesh Kumar; Punit Sharma; Chandrasekhar Bal; Rakesh Kumar
Journal:  Indian J Nucl Med       Date:  2015 Jan-Mar

8.  Novel mass spectrometry-based tool for genotypic identification of mycobacteria.

Authors:  Michael Lefmann; Christiane Honisch; Sebastian Böcker; Niels Storm; Friedrich von Wintzingerode; Cord Schlötelburg; Annette Moter; Dirk van den Boom; Ulf B Göbel
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

9.  Prevalence of tuberculous lymphadenitis in Gondar University Hospital, Northwest Ethiopia.

Authors:  Dagnachew Muluye; Belete Biadgo; Eden Woldegerima; Andebet Ambachew
Journal:  BMC Public Health       Date:  2013-05-03       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.